KMT2A and acute myeloid leukemia: As the expression of a specific cyclin, CCND1, predicts worse survival in MLL fusion AML but not other types of AML, we suggest that a similar mechanism could operate in both mouse and human AMLs initiated by MLL fusion oncogenes (Fig. 9b, c).